# Ingevity Corp (NGVT) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Ingevity Corp's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/NGVT/mda/fy2025/): filed 2026-02-26; accession 0001653477-26-000014 (https://www.sec.gov/Archives/edgar/data/1653477/000165347726000014/ngvt-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/NGVT/mda/fy2024/): filed 2025-02-19; accession 0001653477-25-000015 (https://www.sec.gov/Archives/edgar/data/1653477/000165347725000015/ngvt-20241231.htm)
- [FY 2023 MD&A](/company/NGVT/mda/fy2023/): filed 2024-02-22; accession 0001653477-24-000009 (https://www.sec.gov/Archives/edgar/data/1653477/000165347724000009/ngvt-20231231.htm)
- [FY 2022 MD&A](/company/NGVT/mda/fy2022/): filed 2023-02-28; accession 0001653477-23-000010 (https://www.sec.gov/Archives/edgar/data/1653477/000165347723000010/ngvt-20221231.htm)
- [FY 2021 MD&A](/company/NGVT/mda/fy2021/): filed 2022-02-24; accession 0001653477-22-000008 (https://www.sec.gov/Archives/edgar/data/1653477/000165347722000008/ngvt-20211231.htm)

Back to /company/NGVT/